Riskpilot← Back to searchSign inGet full accessTHOR MEDICAL ASA
ASAActiveOrg 994297422Drammensveien 167, 0277 OsloResearch and experimental development on natural sciences and engineering · NACE 7210Est. 200925 employeeswww.thormedical.no
Revenue 2024
NOK 0
EBITDA margin
—
-892% vs 2023
Equity ratio
93.8%
Financial strength
Net profit 2024
NOK -40,6M
-1322% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -41,9M | -892% |
| Net profit | NOK -40,6M | -1322% |
| Total assets | NOK 363,9M | +31% |
| Equity | NOK 341,5M | +24% |
| Employees | 25 | — |
Legal name
THOR MEDICAL ASA
Org number
994297422
Legal form
Allmennaksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
7. juli 2009
Share capital
NOK 72 000 364
Employees
25 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Levere alfaemittere til leverandører og utviklere av innovative legemidler som retter seg mot indikasjoner med høyt udekket medisinsk behov, inkludert eventuelle medisinske produkter og utstyr, og å drive virksomhet relatert til dette eller forbundet med dette.
Address
Drammensveien 167, 0277 Oslo
Website
www.thormedical.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 0 | 0 | 0 | −4 225 | −41 925 |
| Depreciation & amort. | −0 | −0 | −0 | −131 | −21 |
| EBIT | 0 | 0 | 0 | −4 356 | −41 946 |
| Net financials | 0 | 0 | 0 | 1 501 | 1 353 |
| Profit before tax | 0 | 0 | 0 | −2 855 | −40 593 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 0 | 0 | 0 | −2 855 | −40 593 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | — | — | — | 278 406 | 363 926 |
| Equity | — | — | — | 274 629 | 341 463 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 0 | 0 | 3 777 | 22 462 |
| Total debt | 0 | 0 | 0 | 3 777 | 22 462 |
EBITDA margin
-4192500000.0%
This company
15.8%
Market median
-26534810227% vs market
20202024
Equity ratio
93.8%
This company
38.2%
Market median
+146% vs market
20202024
Return on equity
-11.9%
This company
18.4%
Market median
-165% vs market
20202024
Net profit margin
-4059300000.0%
This company
8.1%
Market median
-50114814915% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.07×
This company
0.62×
Market median
+89% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JC Chief Executive Officer | Chief Executive Officer | 2024 |
| Former (5) | ||
AB Chief Executive Officer | Chief Executive Officer | 2023 – 2024 |
KE Chief Executive Officer | Chief Executive Officer | 2021 – 2022 |
MB Chief Executive Officer | Chief Executive Officer | 2022 – 2023 |
LN Chief Executive Officer | Chief Executive Officer | 2020 – 2021 |
FH Contact Person | Contact Person | 2020 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Board of Directors | 2023 | |
| Chairman | 2025 | |
| Board of Directors | 2025 | |
| Board of Directors | 2025 | |
| Board of Directors | 2025 | |
| Former (10) | ||
| Chairman | 2023 – 2025 | |
| Board of Directors | 2021 – 2022 | |
| Board of Directors | 2023 – 2023 | |
| Chairman | 2022 – 2023 | |
| Board of Directors | 2022 – 2022 | |
| Board of Directors | 2022 – 2022 | |
| Board of Directors | 2023 – 2023 | |
| Board of Directors | 2022 – 2023 | |
| Board of Directors | 2021 – 2022 | |
| Board of Directors | 2022 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 22.97% | 22.97% | 2024 | |
| Company | 4.2% | 4.2% | 2024 | |
| Company | 3.76% | 3.76% | 2024 | |
| Company | 3.26% | 3.26% | 2022 | |
| Company | 2.85% | 2.85% | 2024 | |
| Company | 2.21% | 2.21% | 2024 | |
| Individual | 1.75% | 1.75% | 2022 | |
Nordnet Bank Ab | Company | 1.68% | 1.68% | 2024 |
Dnb Bank Asa | Company | 1.58% | 1.58% | 2024 |
| Individual | 1.53% | 1.53% | 2024 | |
| Company | 1.32% | 1.32% | 2024 | |
| Company | 1.13% | 1.13% | 2024 | |
| Company | 1.04% | 1.04% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Tba Holding As
THOR MEDICAL ASA Board members of THOR MEDICAL ASA also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Alf Bjørseth | Chief Executive Officer | 0 companies |
| Knut Erik Skullerud | Chief Executive Officer | 0 companies |
| Malene Brøndberg | Chief Executive Officer | 0 companies |
| Lars Nieba | Chief Executive Officer | 0 companies |
| Fredrik Haavind | Contact Person | 0 companies |
| Jasper Cornelius Kurth | Chief Executive Officer | 0 companies |
| Ludvik Sandnes | Chairman | 0 companies |
| Mimi Kristine Berdal | Board of Directors | 0 companies |
| Rainer Josef Böhm | Board of Directors | 0 companies |
| John Andersen | Chairman | 0 companies |
| Jens Gisle Schnelle | Board of Directors | 0 companies |
| Tina Bjørnlund Bønsdorff | Board of Directors | 0 companies |
| Jan Hendrik Egberts | Chairman | 0 companies |
| Solveig Elisabeth Hellebust | Board of Directors | 0 companies |
| Jean Pierre Bizzari | Board of Directors | 0 companies |
| Eddie Berglund | Board of Directors | 0 companies |
| Joanna Caroline Horobin | Board of Directors | 0 companies |
| Ann Ulrika Gidner | Board of Directors | 0 companies |
| Per Anders Göte Samuelsson | Board of Directors | 0 companies |
| Karin Judith Meyer | Board of Directors | 0 companies |
| Thomas Ramdahl | Board of Directors | 0 companies |